A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 15, Issue 1, 2003, Pages 17-26

  Griffin, Stefanie L ^a   Van Reekum, Robert ^b,c   Masanic, Cheryl ^d  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; CITICOLINE; DONEPEZIL; METHYLPHENIDATE; PHOSPHATIDYLCHOLINE; PHYSOSTIGMINE;

ALZHEIMER DISEASE; AROUSAL; BEHAVIOR DISORDER; BRAIN INJURY; CHOLINERGIC SYSTEM; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; MEMORY; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW;

EID: 0037412784     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.15.1.17     Document Type: Review

References (71)

1. Kraus JF, Black MA, Ilessol N, et al: The incidence of acute brain injury and serious impairment in defined populations. Am J Epidemiol 1984; 119:185-201
2. Klasbeek WD, McLaruin RL, Harris BSH, et al: The national head and spinal cord survey findings. J Neurosurg 1980; 53:519-531
3. NIH Consensus Development Panel on Rehabilitation of Persons with Traumatic Brain Injury: Rehabilitation of persons with traumatic brain injury. JAMA 1998; 282:974-983
4. Brooks DN, McKinlay W, Symington C, et al: Return to work within seven years of severe head injury. Brain Inj 1987; 1:5-19
5. Fraser R, Dikmen S, McLean A, et al: Employability of head injury survivors: first year post-injury. Rehabilitation Counseling Bulletin 1988; 31:276-288
6. Ip RY, Dornan J, Schentag C: Traumatic brain injury: factors predicting return to work or school. Brain Inj 1995; 9:517-532
7. Dikmen S, Machamer J, Savoie T, et al: Life quality outcome in head injury, in Neuropsychological Assessment of Neuropsychiatric Disorders, 2nd edition. Edited by Grant I, Adams K. New York, Oxford University Press, 1996, pp 552-576
8. Little AJ, Templer DI, Persel, et al: Feasibility of the neuropsychological spectrum in prediction of outcome following head injury. J Clin Psychol 1996; 52:455-460
9. Millis SR, Rosenthal M, Lourie IF: Predicting community integration after traumatic brain injury with neuropsychological measures. Int J Neurosci 1994; 79:165-167
10. Colantonio A, Dawson DR, McLellan BA: Head injury in young adults: long-term outcome. Arch Phys Med Rehabil 1998; 79:550-558
11. Salazar AM, Warden DL, Schwab K, et al: Cognitive rehabilitation for traumatic brain injury: a randomized trial. JAMA 2000; 283:3075-3081
12. Lawrence AD, Sahakian BJ: Alzheimer disease, attention, and the cholinergic system. Alzheimer Dis Assoc Disord 1995; 9:43-49
13. Bartus RT, Dean RL, Beer B, et al: The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217:408-417
14. Riekkinen M, Soininen H, Riekkinen P, et al: Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease. Neuroscience 1997; 83:471-479
15. Rogers SL, Friedhoff LT, the Donepezil Study Group: The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia 1996; 7:293-303
16. Rogers SL, Doody RS, Mohs RC, et al: Donepezil improves cognition and global function in Alzheimer disease. Arch Intern Med 1998; 158:1021-1031
17. Simard M, van Reekum R: Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease. Drugs Aging 1998; 14:197-230
18. McIntosh TK, Juhler M, Wieloch T: Novel pharmacological strategies in the treatment of experimental traumatic brain injury. J Neurotrauma 1998; 15:731-769
19. Dewar D, Graham DI: Depletion of choline acetyltransferase activity but preservation of M1 and M2 muscarinic receptor binding sites in temporal cortex following head injury: a preliminary human postmortem. J Neurotrauma 1996; 13:181-187
20. Murdoch I, Perry EK, Court JA, et al: Cortical cholinergic dysfunction after human head injury. J Neurotrauma 1998; 15:295-305
21. Shao L, Ciallella JR, Yan HQ, et al: Differential effects of traumatic brain injury of vesicular acetylcholine transporter and MS muscarinic receptor mRNA and protein in rat. J Neurotrauma 1999; 16:555-566
22. Arcieniegas D, Adler L, Topkoff J, et al: Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating and a hypothesis for further investigation. Brain Inj 1999; 13:1-13
23. Kaitaro T, Koskinen S, Kaipio M-L: Neuropsychological problems in everyday life: a 5-year follow-up study of young severely closed-head-injured patients. Brain Inj 1995; 9:713-727
24. Pike BR, Hamm RJ: Postinjury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats. Brain Res 1995; 686:37-43
25. A receptor, and cognitive impairment in rats following traumatic brain injury. J Neurosurg 1995; 83:878-883
26. Dixon CE, Ma X, Marion DW: Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J Neurotrauma 1997; 14:161-169
27. Rusted JM, Warburton DM: Cognitive models and cholinergic drugs. Neuropsychology 1989; 21:31-36
28. Drachman DA: Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 1977; 27:783-790
29. Nissen MJ, Knopman DS, Schacter DL: Neurochemical dissociation of memory systems. Neurology 1987; 37:789-794
30. Cummings JL: Cholinesterase inhibitors: a new class of psychotropic compounds. Am J Psychiatry 2000; 157:4-15
31. Levin HS, Goldstein FC: Organization of verbal memory after severe closed-head injury. J Clin Exp Neuropsychol 1986; 8:643-656
32. Weingartner H, Grafman J, Boutelle W, et al: Forms of memory failure. Science 1983; 221:380-382
33. Masanic CA, Bayley MT, van Reekum, R, et al: Open-label study of donepezil in traumatic brain injury. Arch Phys Med Rehabil 2001; 82:896-901
34. Eames P, Sutton A: Protracted post-traumatic confusional state treated with physostigmine. Brain Inj 1995; 9:729-734
35. Weinberg RM, Auerbach SH, Moore S: Pharmacologic treatment of cognitive deficits: a case study. Brain Inj 1987; 1:57-59
36. Cardenas DD, McLean A, Farrell-Roberts L, et al: Oral physostigmine and impaired memory in adults with brain injury. Brain Inj 1994; 8:579-587
37. Walton RG: Lecithin and physostigmine for posttraumatic memory and cognitive deficits. Psychosomatics 1982; 23:435-436
38. Goldberg E, Gerstman LJ, Mattis S, et al: Effects of cholinergic treatment on post-traumatic anterograde amnesia. Arch Neurol 1982; 39:581
39. Levin HS, Peters BH, Kalisky Z, et al: Effects of oral physostigmine and lecithin on memory and attention in closed head injured patients. Central Nervous System Trauma 1986; 3:333-342
40. Levin HS: Treatment of postconcussional symptoms with CDP-choline. J Neurol Sci 1991; 103:S39-S42
41. Spiers PA, Hochanadel G: Citicoline for traumatic brain injury: report of two cases, including my own. J Int Neuropsychol Soc 1999; 5:260-264
42. Maldonado VC, Perez JBC, Escario JA: Effects of CDP-choline on the recovery of patients with head injury. J Neurol Sci 1991;103: S15-S18
43. Leon-Carrion J, Dominguez-Roldan JM, Murill-Cabezas F, et al: The role of citicholine in neuropsychological training after traumatic brain injury. Neurorehabilitation 2000; 14:33-40
44. Taverni JP, Seliger G, Lichtman SW: Donepezil mediated memory improvement in traumatic brain injury during post acute rehabilitation. Brain Inj 1998; 12:77-80
45. Whelan F, Walker MS, Schultz SK: Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. Ann Clin Psychiatry 2000; 12:131-135
46. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
47. Marin RS, Biedrzycki RC, Firinciogullari S: Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991; 38:143-162
48. Kant R, Duffy JD, Pivovarnik A: Prevalence of apathy following head injury. Brain Inj 1998; 12:87-92
49. Andersson S, Krogstad JM, Finset A: Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity. Psychol Med 1999; 29:447-456
50. Cummings JL: Changes in neuropsychiatric symptoms as outcome measures in clinical trials with cholinergic therapies for Alzheimer disease. Alzheimer Dis Assoc Disord 1997; 11:S1-S9
51. Cummings JL, Back C: The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. Am J Geriatr Psychiatry 1998; 6:S64-S78
52. Mesulam M-M, Mufson EJ, Levey AI, et al: Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 1983; 214:170-197
53. Kaufer D, Cummings JL, Christine D: Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity. J Neuropsychiatry Clin Neurosci 1998; 10:55-63
54. Levy ML, Cummings JL, Kahn-Rose R: Neuropsychiatric symptoms of cholinergic therapy for Alzheimer's disease. Gerontology 1999; 45: S15-S22
55. Mega MS, Masterman DM, O'Connor SM, et al: The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Arch Neurol 1999; 56:832-842
56. Rey A: L'examen clinique en psychologie. Paris: Presses Universitaires de France, 1964
57. Osterrieth PA: Le test de copie d'une figure complexe. Archives de Psychologie 1944; 30:206-356
58. Peterson LR, Peterson MJ: Short-term retention of individual verbal items. J Exp Psychol 1959; 58:193-198
59. Conners CK, Multi-Health Systems Staff: Conners' Continuous Performance Test. Toronto, MHS, 1995
60. Wechsler D: WAIS-R manual. New York, The Psychological Corporation, 1981
61. Reitan RM, Wolfson D: The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson, AZ, Neuropsychology Press, 1993
62. Grant DA, Berg EA: A behavioral analysis of the degree of reinforcement and ease of shifting to new responses in a Weigl-type card sorting problem. J Exp Psychol 1948; 38:404-411
63. Benton AL, Hamsher KdeS: Multilingual Aphasia Examination. Iowa City, IA, AJA Associates, 1989
64. Katz MM, Lyerly SB: Methods for measuring adjustment and social behavior in the community, I: rationale, description, discriminative validity and scale development. Psychol Rep 1963; 13:503-535
65. Levin HS, High WM, Goethe KE, et al: The Neurobehavioral Rating Scale assessment of the behavioral sequelae of head injury by the clinician. J Neurol Neurosurg Psychiatry 1987; 50:183-193
66. Lezak M: Neuropsychological Assessment, 3rd edition. New York, Oxford University Press, 1995
67. Kibby MY, Schmitter-Edgecombe M, Long C: Ecological validity of neuropsychological tests: focus on the California Verbal Learning Test and the Wisconsin Card Sorting Test. Archives of Clinical Neuropsychology 1998; 13:523-534
68. Levin HS, Grossman RG, Rose JE, et al: Long-term neuropsychological outcome of closed head injury. J Neurosurg 1979; 50:412-422
69. Bergner M, Bobbitt RA, Carter WB, et al: The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19:787-805
70. Ben-Yishay Y, Silver S, Piasetsky E, et al: Relationship between employability and vocational outcome after intensive holistic cognitive rehabilitation. J Head Trauma Rehabil 1987; 2:35-48
71. Willer B, Rosenthal M, Kreutzer JS, et al: Assessment of community integration following rehabilitation for traumatic brain injury. J Head Trauma Rehabil 1983; 8:75-87